Stem cell therapy for heart disease: Truly beneficial?

Netherlands Heart Journal

Volumn 22, Issue 7-8, 2014, Pages 313-315

  van der Wall, E E ^a  

^a ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MORTALITY; CONGESTIVE HEART FAILURE; EDITORIAL; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL TRANSPLANTATION;

EID: 84904554950     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-014-0568-2     Document Type: Editorial

References (15)

1. van Ramshorst J, Bax JJ, Beeres SL, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA. 2009;301:1997-2004. doi:10.1001/jama. 2009.685.
2. Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of STsegment elevation myocardial infarction: a collaborative metaanalysis. Eur Heart J. 2014;35:989-98. doi:10.1093/eurheartj/eht372.
3. van Vliet P, Roccio M, Smits AM, et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J. 2008;16:163-9.
4. Freund C, Davis RP, Gkatzis K, et al. The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J. 2010;18:51-4.
5. van der Laan A, Hirsch A, Nijveldt R, et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J. 2008;16:436-9.
6. Robbers LF, Nijveldt R, Beek AM. et al; HEBE investigators. Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? Neth Heart J. 2012;20:133-7.
7. Hirsch A, Nijveldt R, van der Vleuten PA, et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J. 2011;32:1736-47. doi:10.1093/eurheartj/ehq449.
8. Nowbar AN, Mielewczik M, Karavassilis M, et al. DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014;348:g2688. doi:10. 1136/bmj.g2688.
9. Husten L. Stem cell therapy to fix the heart: a house of cards about to fall? Pharm Healthcare. Forbes Magazine, 28 April 2014
10. Kajstura J, Rota M, Cappetta D, et al. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012;126:1869-81. doi:10 1161/CIRCULATIONAHA.112.118380. Epub 2012 Sep 6. Retraction in: Circulation. 2014;129:e466.
11. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy(SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-57. doi:10.1016/ S0140-6736(11)61590-0.
12. van der Wall EE. A broken heart; repair needed? Neth Heart J. 2012;20:1-2. doi:10.1007/s12471-011-0229-7.
13. Francis DP, Mielewczik M, Zargaran D, et al. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int J Cardiol. 2013;168:3381-403. doi:10.1016/ j.ijcard.2013.04.152.
14. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol. 2005;46:1651-8.
15. Mielewczik M, Cole GD, Nowbar AN, et al. The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failure). J Am Coll Cardiol. 2013;62:2453. doi:10.1016/j.jacc.2013. 09.013.